Search Results - Pierre Labauge
- Showing 1 - 2 results of 2
-
1
Durable B‐Cell Impairment While Sparing IgA B Cells After Ocrelizumab Therapy in Multiple Sclerosis Autoría: Alexandra Garcia, Stephane Rodriguez, Emilie Dugast, Christine Lebrun‐Frenay, Eric Thouvenot, Jérôme de Sèze, Emmanuelle Le Page, Sandra Vukusic, Inès Doghri, Eric Berger, Olivier Casez, Pierre Labauge, Aurélie Ruet, Catarina Raposo, Fabienne Le Frère, Arnaud B. Nicot, Sandrine Wiertlewski, Pierre‐Antoine Gourraud, Laure Michel, Laureline Berthelot, David‐Axel Laplaud
Published 2025Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
2
Secondary progression activity monitoring in MS despite an early highly active treatment the SPAM study Autoría: Mikael Cohen, Fabien Rollot, Marc Debouverie, Hélène Zephir, Sandra Vukusic, Jérome De Seze, Pierre Labauge, Cassandre Landes‐Chateau, Lydiane Mondot, Michael Levraut, Aurélie Ruet, Eric Berger, David Laplaud, Jonathan Ciron, Bertrand Bourre, Emmanuelle Le Page, Caroline Papeix, Eric Thouvenot, Abdullatif Al Khedr, Bruno Stankoff, Jean Pelletier, Elisabeth Maillart, Olivier Casez, Thibault Moreau, Gilles Defer, Pierre Clavelou, Philippe Cabre, Solène Moulin, Jean Philippe Neau, Mickael Zedet, Karolina Hankiewicz, Inès Doghri, Haifa Ben Nasr, Corinne Pottier, Laurent Magy, Dalia Dimitri Boulos, Olivier Heinzlef, Jean Philippe Camdessanche, Marc Coustans, Chantal Nifle, David Brassat, Romain Casey, Christine Lebrun‐Frenay
Published 2025Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso